ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : host response
Field of Research : Medical Bacteriology
Clear All
Filter by Field of Research
Medical Bacteriology (28)
Medical Microbiology (2)
Clinical Sciences not elsewhere classified (1)
Immunology not elsewhere classified (1)
Medical Biotechnology not elsewhere classified (1)
Medicinal and Biomolecular Chemistry not elsewhere classified (1)
Filter by Socio-Economic Objective
Disease Distribution and Transmission (incl. Surveillance and Response) (2)
Expanding Knowledge in the Medical and Health Sciences (1)
Infectious Diseases (1)
Preventive Medicine (1)
Soaps and Cosmetics (1)
Filter by Funding Provider
National Health and Medical Research Council (26)
Australian Research Council (2)
Filter by Status
Closed (28)
Filter by Scheme
Project Grants (12)
NHMRC Project Grants (8)
Early Career Fellowships (4)
Career Development Fellowships (2)
Linkage Projects (2)
Filter by Country
Australia (3)
Filter by Australian State/Territory
VIC (2)
NSW (1)
  • Researchers (5)
  • Funded Activities (28)
  • Organisations (12)
  • Funded Activity

    Host-pathogen Interactions In Clostridial Myonecrosis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $577,573.00
    Summary
    We will analyse the interaction between the bacteria that cause gas gangrene, and the infected host, from both a host and pathogen perspective. We will examine how the host’s response to infection can be modulated to decrease the severity of disease and we will identify the biochemical processes that are essential for bacterial growth in the host, a necessary prerequisite for disease. Outcomes will be a better understanding of the mechanisms of disease causation and improved disease control.
    More information
    Funded Activity

    Iron, Pseudomonas Aeruginosa And Lung Disease In Cystic Fibrosis.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $322,875.00
    Summary
    Cystic fibrosis (CF) is the most common lethal geneticdisease in Caucasians. The worldwide incidence of the disorder is approximately 1 in 2,500 live births. The most significant clinical manifestation of CF is chronic lung infection, particularly with the bacterium, Pseudomonas aeruginosa. Even with the current aggressive antibiotic treatment regimens most patients ultimately succumb to infection with this organism and die before they reach 40 years-of-age. The overall aim of our work is to inc .... Cystic fibrosis (CF) is the most common lethal geneticdisease in Caucasians. The worldwide incidence of the disorder is approximately 1 in 2,500 live births. The most significant clinical manifestation of CF is chronic lung infection, particularly with the bacterium, Pseudomonas aeruginosa. Even with the current aggressive antibiotic treatment regimens most patients ultimately succumb to infection with this organism and die before they reach 40 years-of-age. The overall aim of our work is to increase the understanding of how P. aeruginosa persists in the CF lung, with the goal of developing more effective therapeutic strategies to eliminate chronic infection with this bacterium. The new perception is that P. aeruginosa bacteria flourish in mucus with a low oxygen content within the CF lung and persist despite aggressive antibiotic therapy because they have adopted an antibiotic-resistant, biofilm mode of growth. This has opened up exciting directions for new therapeutic strategies. Factors in CF mucus that regulate this mode of bacterial growth are potential targets for intervention. Our past work has shown that iron is likely to be one such factor. In this study, we will extend these findings and determine whether using iron-binding chemicals can disrupt these biofims and allow the host immune system and antibiotics to work more efficiently to kill the bacteria. Not only will this study provide further insights into the pathogenesis of P. aeruginosa in CF and the role of iron, but ultimately it will contribute to the improved treatment and prevention of chronic infection with this organism.
    Read more Read less
    More information
    Funded Activity

    Understanding The Complex Relationship Between Host, Pathogen And Antibiotic Factors On Treatment Outcome In Serious Bacterial Infections

    Funder
    National Health and Medical Research Council
    Funding Amount
    $380,945.00
    Summary
    Millions of people still die every year from bacterial infections despite the availability of antibiotics. The same bacterial infection in one person can behave very differently in another person, so infections can range from trivial to life-threatening or fatal. Understanding the relationship between the patient, the infecting bacteria and the antibiotic treatment given will ultimately help to predict and improve outcomes for patients with serious bacterial infections.
    More information
    Funded Activity

    Inhibition Of Haemostasis As A Novel Host-directed Therapy For Tuberculosis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $528,471.00
    Summary
    Mycobacterium tuberculosis-induced vasculopathy is an important cause of stroke worldwide, and stroke is a common (~20%) complication of tuberculous meningitis, the most dangerous presentation of tuberculosis. Blood clotting may also speed the growth tuberculosis in the body further worsening the situation. We will use zebrafish find out if clotting can be targeted to slow the growth of mycobacteria and then translate our findings to a mouse model of pulmonary tuberculosis.
    More information
    Funded Activity

    Genes Of Mycobacterium Tuberculosis Essential For Latent Tuberculosis Infection

    Funder
    National Health and Medical Research Council
    Funding Amount
    $590,103.00
    Summary
    One third of the worlds population is latently infected with M. tuberculosis, the bacteria which causes TB. We have identified key genes in M. tuberculosis that enable the bacterium to shut-down and become latent. This project will investigate these genes, identify their role and yield vital information for a new paradigm of drug and vaccine development. Improved vaccines and drugs which can target and inhibit latency would be of enormous benefit to the global community.
    More information
    Funded Activity

    Understanding The Role Of O-linked Glycosylation In Burkholderia Cenocepica For Host Survival Using Proteomic Approaches

    Funder
    National Health and Medical Research Council
    Funding Amount
    $222,004.00
    Summary
    The bacteria Burkholderia cenocepecia (Bc) is a common infection of Cystic Fibrosis suffers in Australia. ~20% CF patients infected with Bc will die due to lung failure. Due to this high death rate there is an urgent need to understand how Bc survives and causes disease in the host. This grant aims to understand how the attachment of sugars, a process known as glycosylation, affects the ability of Bc to survive in mammalian cells.
    More information
    Funded Activity

    Functional Characterisation Of The SseK Family Of Effectors In Salmonella

    Funder
    National Health and Medical Research Council
    Funding Amount
    $178,937.00
    More information
    Funded Activity

    Host-pathogen Interactions In Clostridial Myonecrosis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $897,617.00
    Summary
    This project will show how the bacteria that cause gas gangrene interact with host cells in an infection. We will examine the expression of genes from both the host and the pathogen in a mouse disease model. The aims are to determine the impact of bacterial genes that are differentially regulated in an infected lesion, how gene expression of both the host and pathogen is modulated throughout the course of an infection and the role of host pathways in controlling the infection process.
    More information
    Funded Activity

    The Glyco-interactome Of Pathogenic Neisseria: Understanding Disease And Defining Vaccine Targets

    Funder
    National Health and Medical Research Council
    Funding Amount
    $431,012.00
    Summary
    In order to infect humans and cause disease, many bacteria rely on interactions with carbohydrate (sugar) structures on human cells. This project aims to characterise the sugar interactions that enable Neisseria meningitidis (causes meningitis, sepsis) and Neisseria gonorrhoeae (causes gonorrhoea, associated with infertility and increased transmission of HIV) to cause disease. This will increase our understanding of host-pathogen interactions and aid development of new vaccines and therapeutics.
    More information
    Funded Activity

    Evaluation Of Haemophilus Haemolyticus As A Preventative Therapy For NTHi Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $445,659.00
    Summary
    Middle ear infections are the most common reason for a child to be given antibiotics and undergo surgery. This project will investigate whether a harmless bacterium found in the respiratory tract of children can be used as a probiotic to prevent bacterial ear infections. Benefits from reducing ear infections include fewer children undergoing surgery, fewer GP visits and antibiotic prescriptions, less time off work for parents, reduced hearing loss in children, and improved educational outcomes.
    More information

    Showing 1-10 of 28 Funded Activites

    • 1
    • 2
    • 3
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback